Gardasil For Males Gets FDA OK; Next Up, Cost-Effectiveness Questions
This article was originally published in The Pink Sheet Daily
Executive Summary
CDC's Advisory Committee on Immunization Practices is slated to consider at an Oct. 21 meeting whether to recommend the vaccine to prevent genital warts in males.
You may also be interested in...
Merck Looks To Mid-June FDA Decision On Expanded Use Of Gardasil To Older Women
Company unveils data at European conference supporting use in women ages 27 through 45; data was sent to FDA late last year.
Merck Looks To Mid-June FDA Decision On Expanded Use Of Gardasil To Older Women
Company unveils data at European conference supporting use in women ages 27 through 45; data was sent to FDA late last year.
FDA To Decide On Expanded Use Of Gardasil In Older Women In Mid-June
Merck anticipates receiving an FDA decision by mid-June on expanding use of its human papillomavirus Gardasil to women aged 27 through 45